NCT01289886View on ClinicalTrials.gov

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

November 30, 2003

Study Completion Date

December 31, 2003

Conditions
Essential Hypertension
Interventions
DRUG

BR-A-657

20, 60, 120, 240, 360, 480mg or placebo tablet

Sponsors

Collaborators (1)

Covance
All Listed Sponsors
collaborator

Covance

INDUSTRY

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY